Walleye Capital LLC Viridian Therapeutics, Inc.\De Transaction History

Walleye Capital LLC

$46.2 Billion
Q3 2024

A detailed history of Walleye Capital LLC transactions in Viridian Therapeutics, Inc.\De stock. As of the latest transaction made, Walleye Capital LLC holds 560,007 shares of VRDN stock, worth $11.1 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

560,007

Previous 430,596 30.05%

Holding current value

$11.1 Million

Previous $5.6 Million 127.42%

% of portfolio

0.03%

Previous 0.01%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$12.16 - $23.33 $1.57 Million - $3.02 Million	129,411 Added 30.05%	560,007 $12.7 Million
Q2 2024 Aug 14, 2024	BUY	$11.6 - $17.26 $4.93 Million - $7.33 Million	424,960 Added 7540.1%	430,596 $5.6 Million
Q1 2024 May 15, 2024	SELL	$17.09 - $23.82 $4.03 Million - $5.62 Million	-235,775 Reduced 97.67%	5,636 $98,000
Q4 2023 Feb 14, 2024	BUY	$11.12 - $22.5 $2.53 Million - $5.13 Million	227,881 Added 1684.26%	241,411 $5.26 Million
Q3 2023 Nov 14, 2023	SELL	$15.16 - $24.7 $1.12 Million - $1.82 Million	-73,590 Reduced 84.47%	13,530 $207,000
Q2 2023 Aug 14, 2023	SELL	$22.57 - $29.67 $666,650 - $876,362	-29,537 Reduced 25.32%	87,120 $2.07 Million
Q1 2023 May 15, 2023	BUY	$25.04 - $37.6 $1.77 Million - $2.65 Million	70,515 Added 152.82%	116,657 $2.97 Million
Q4 2022 Feb 14, 2023	SELL	$18.78 - $29.74 $2.69 Million - $4.26 Million	-143,387 Reduced 75.65%	46,142 $1.35 Million
Q3 2022 Nov 14, 2022	BUY	$10.7 - $25.5 $118,534 - $282,489	11,078 Added 6.21%	189,529 $3.89 Million
Q2 2022 Aug 08, 2022	BUY	$9.55 - $19.0 $154,423 - $307,230	16,170 Added 9.96%	178,451 $2.07 Million
Q1 2022 May 16, 2022	BUY	$16.79 - $20.88 $874,859 - $1.09 Million	52,106 Added 47.29%	162,281 $3 Million
Q4 2021 Mar 03, 2022	BUY	$15.65 - $21.5 $1.37 Million - $1.88 Million	87,674 Added 389.64%	110,175 $2.18 Million
Q3 2021 Nov 15, 2021	BUY	$10.69 - $18.2 $240,535 - $409,518	22,501 New	22,501 $370,000

Others Institutions Holding VRDN

# of Institutions

179

Shares Held

76.8M

Call Options Held

581K

Put Options Held

439K

View Full List

About Viridian Therapeutics, Inc.\DE

Ticker VRDN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,888,900
Market Cap $789M
Description
Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody, which is in Phase 1 clinical trial; and VRDN-00...

More about VRDN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.

Account

Walleye Capital LLC Viridian Therapeutics, Inc.\De Transaction History